Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03586973 |
|---|---|
| Brief Title: | A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma |
| First Submitted : | June 29, 2018 |
| First Submitted that Met QC Criteria : | July 12, 2018 |
| First Posted : | July 16, 2018 |
| Last Update Submitted that Met QC Criteria : | August 25, 2021 |
| Last Update Posted : | August 27, 2021 |